Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
HealthCentral CEO Justin Chase joins to discuss the drops app and its mission to combat medical misinformation and improve access to trusted health info.
Rob Thummel of Tortoise Capital breaks down oil prices, geopolitical risks, and what a volatile energy market could mean for investors and consumers this summer
